411 related articles for article (PubMed ID: 8806767)
21. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
22. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
23. Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression during cardiac neural crest cell migration and its role in proMMP-2 activation.
Cantemir V; Cai DH; Reedy MV; Brauer PR
Dev Dyn; 2004 Dec; 231(4):709-19. PubMed ID: 15497141
[TBL] [Abstract][Full Text] [Related]
24. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation.
Benyon RC; Hovell CJ; Da Gaça M; Jones EH; Iredale JP; Arthur MJ
Hepatology; 1999 Oct; 30(4):977-86. PubMed ID: 10498650
[TBL] [Abstract][Full Text] [Related]
25. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
[TBL] [Abstract][Full Text] [Related]
27. An analysis of the conformational changes that accompany the activation and inhibition of gelatinase A.
Crabbe T; Kelly SM; Price NC
FEBS Lett; 1996 Feb; 380(1-2):53-7. PubMed ID: 8603746
[TBL] [Abstract][Full Text] [Related]
28. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
[TBL] [Abstract][Full Text] [Related]
29. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
[TBL] [Abstract][Full Text] [Related]
30. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
31. A matrix metalloproteinase proenzyme activator produced by articular cartilage.
Towle CA; Wright M; Hecht AC; Kuong SJ; Papanicolas LE; Totkovic R; Mankin HJ; Treadwell BV
Biochem Biophys Res Commun; 1998 Jun; 247(2):324-31. PubMed ID: 9642125
[TBL] [Abstract][Full Text] [Related]
32. Stepwise activation mechanisms of the precursors of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin).
Nagase H; Suzuki K; Enghild JJ; Salvesen G
Biomed Biochim Acta; 1991; 50(4-6):749-54. PubMed ID: 1666284
[TBL] [Abstract][Full Text] [Related]
33. Cloning, expression, and characterization of chicken tissue inhibitor of metalloproteinase-2 (TIMP-2) in normal and transformed chicken embryo fibroblasts.
Aimes RT; Li LH; Weaver B; Hawkes S; Hahn-Dantona EA; Quigley JP
J Cell Physiol; 1998 Mar; 174(3):342-52. PubMed ID: 9462696
[TBL] [Abstract][Full Text] [Related]
34. TIMP-2 is required for efficient activation of proMMP-2 in vivo.
Wang Z; Juttermann R; Soloway PD
J Biol Chem; 2000 Aug; 275(34):26411-5. PubMed ID: 10827175
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A
Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963
[TBL] [Abstract][Full Text] [Related]
36. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP.
Hernandez-Barrantes S; Shimura Y; Soloway PD; Sang QA; Fridman R
Biochem Biophys Res Commun; 2001 Feb; 281(1):126-30. PubMed ID: 11178970
[TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
[TBL] [Abstract][Full Text] [Related]
38. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts.
Li L; Akers K; Eisen AZ; Seltzer JL
Exp Cell Res; 1997 May; 232(2):322-30. PubMed ID: 9168808
[TBL] [Abstract][Full Text] [Related]
39. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
[TBL] [Abstract][Full Text] [Related]
40. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
